Johns Hopkins Wilmer Eye Institute’s MACULA and the 5th Annual Retina Festival 2025

• Target Audience: ophthalmologists
• Sample video: contact me for sample video
• Information:

Target Audience Specialties – Ophthalmology

Overview

Objectives

Explain the biologic rationale for targeting vascular endothelial growth factors in the treatment of the neovascular form of age-related macular degeneration, diabetic retinopathy, and related diseases.

Discuss new imaging and therapeutic approaches to diabetic retinopathy, vitreomacular interface abnormalities, intraocular tumors, posterior uveitis, hereditary retinal degenerations, as well as surgical diseases of the retina.

Evaluate recent clinical studies evaluating treatments for retinal degenerations.

The Johns Hopkins Wilmer Eye Institute’s MACULA and the 5th Annual Retina Festival 2025 is tailored for:

Ophthalmologists: Specialists interested in the latest advancements in retinal diseases and treatments.

Optometrists: Professionals seeking to deepen their knowledge of macular and retinal care.

Ophthalmic Allied Health Professionals: Individuals involved in supporting retinal diagnostics and therapies.

The event focuses on cutting-edge research, imaging techniques, and therapeutic approaches for retinal diseases.

• Topics:

*Note: these are continuous video recordings during the conference, they include individual lectures mentioned in the Detail section below

Choroidal Neovascularization.mp4

Contemporary Retinal Imaging.mp4

Diabetic Macular Edema.mp4

Geographic Atrophy And Inhererited Retinal Diseases.mp4

Keynotes.mp4

Ocular Tumors.mp4

Proliferative Diabetic Retinopathy.mp4

Retinal Vascular Diseases Other than Diabetic Retinopathy.mp4

Special Topics in Retina 2025.mp4

* Detail:

Saturday, January 11, 2025

Welcome; Conference Goals; Introduction of Keynote Talk

Neil Bressler, MD

Welcome; Conference Goals; Introduction of Keynote Talk

J. Fernando Arevalo, MD, PhD

Keynote Talk: Global Influence of NIH Funded Retina Networks

Daniel F Martin, MD

Contemporary Retinal Imaging – MODERATOR

Amir H Kashani, MD, PhD

Contemporary Retinal Imaging – MODERATOR

Christina Y. Weng, MD, MBA

Contemporary Retinal Imaging – MODERATOR

John B Miller, MD

Home Monitoring for Age-related Macular Degeneration

Christina Y. Weng, MD, MBA

Managing Retina with OCT Angiography

Amir H Kashani, MD, PhD

Ultrawide Field Imaging in Diabetic Retinopathy

Paolo S Silva, MD

Imaging Geographic Atrophy: Autofluorescence, OCT, Photos

Glenn Jaffe, MD

Questions and Answers / Discussion

Geographic Atrophy and Inherited Retinal Diseases – MODERATOR

Demetrios Vavvas, MD, PhD

Geographic Atrophy and Inherited Retinal Diseases – MODERATOR

Mandeep Singh, MD, PhD

Geographic Atrophy and Inherited Retinal Diseases – MODERATOR

Stephen Tsang, MD, PhD

Treating Geographic Atrophy: Balancing Benefits and Risks

Demetrios Vavvas, MD, PhD

Clinical Trials for Inherited Retinal Diseases

Mandeep Singh, MD, PhD

Vitamin Supplements for GA or RP: Vitamin A? Not Today

Jason Comander, MD, PhD

Gene Therapy for Retinal/Choroidal Vascular Diseases

Peter A Campochiaro, MD

Retinal Vascular Diseases Other Than Diabetic Retinopathy- MODERATOR

Alexander J Brucker, MD

Retinal Vascular Diseases Other Than Diabetic Retinopathy- MODERATOR

James Handa, MD

Retinal Vascular Diseases Other Than Diabetic Retinopathy- MODERATOR

Sunir Garg, MD

Macular Edema from RVO: Does It Matter Which Anti-VEGF

Aleksandra Rachitskaya, MD

Challenges of Sickle Cell Retinopathy

Jennifer I Lim, MD

Treating MacTel: Just Anatomy or Function Too

Emily Chew, MD

ROP and Other Pediatric Retinal Vascular Diseases

Yoshihiro Yonekawa, MD

Questions and Answers / Discussion

Ocular Tumors

David H Abramson, MD

Ocular Tumors – MODERATOR

Carol L Shields, MD

Ocular Tumors – MODERATOR

Ivana Kim, MD

Radiation Retinopathy

Arun D. Singh, MD

Updates on Retinoblastoma and Histiocytosis

Jasmine Francis, MD

Evolving Treatments in Choroidal Melanoma

Carol L Shields, MD

Oncology Drug Toxicities for the Retina Specialist

William F Mieler, MD

Questions and Answers / Discussion

Introduction: International Keynote Talk and 100th Celebration

J. Fernando Arevalo, MD, PhD

Introduction: International Keynote Talk and 100th Celebration

Neil Bressler, MD

International Keynote Talk: AI Revolution in Retina

Haotian Lin, MD, PhD

Choroidal Neovascularization -MODERATOR

Lucia Sobrin, MD

Choroidal Neovascularization -MODERATOR

Akrit Sodhi, MD, PhD

Choroidal Neovascularization -MODERATOR

Adam S Wenick, MD, PhD

Fixed Dosing, As Needed, or Treat and Extend for CNV

Akrit Sodhi, MD, PhD

Polypoidal Choroidal Vasculopathy: Special Considerations

K. Bailey Freund, MD

Safety Considerations: Inflammation / Occlusive Vasculitis

Andre Witkin, MD

Questions and Answers / Discussion

Proliferative Diabetic Retinopathy – MODERATOR

K. Bailey Freund, MD

Proliferative Diabetic Retinopathy – MODERATOR

John Thompson, MD

Proliferative Diabetic Retinopathy – MODERATOR

Richard B Rosen, MD

Proliferative Diabetic Retinopathy: Anti-VEGF, PRP, or Both

Lee M Jampol, MD

Evolving Indications for Surgery in Proliferative DR

Dean Eliott, MD

Questions and Answers / Discussion

Current Role of Fluorescein Angiography in DME

Yannis Mantas Paulus, MD

Diabetic Macular Edema – MODERATOR

Mira Sachdeva, MD, PhD

Diabetic Macular Edema – MODERATOR

Allen C Ho, MD

Diabetic Macular Edema – MODERATOR

Ishrat Ahmed, MD, PhD

New Agents for DME: Just Durable or More Durable

Judy E Kim, MD

Port Delivery System Updates for DME

Carl D Regillo, MD

AI in DME: At Its Infancy or A Flash in the Pan

T. Y. Alvin Liu, MD

Approaches to Prevent Worsening of Diabetic Retinopathy

Neil Bressler, MD

Questions and Answers / Discussion

Big Data and Social Determinants of Health in Retinal Diseases

Cindy X Cai, MD

Special Topics in Retina for 2025 – MODERATOR

Lee M Jampol, MD

Special Topics in Retina for 2025 – MODERATOR

Joseph Anaya, MD, MBA

Special Topics in Retina for 2025 – MODERATOR

Jose S Pulido, MD, MPH, Professor

Panel Discussion: Women in Retina in 2025

Adrienne Scott, MD

Panel Discussion: Women in Retina in 2025

Judy E Kim, MD

Panel Discussion: Women in Retina in 2025

Jasmine Francis, MD

Panel Discussion: Women in Retina in 2025 – MODERATOR

Jennifer I Lim, MD

New Agents for nAMD: Just Durable or More Durable

Susan Bressler, MD

Therapies for Central Serous Chorioretinopathy

Jay Chhablani, MD

Summary: MACULA 2025 and Plans for MACULA 2026

J. Fernando Arevalo, MD, PhD

Summary: MACULA 2025 and Plans for MACULA 2026

Neil Bressler, MD